Hamilton Lane Advisors’s Insmed INSM Stock Holding History

Hamilton Lane Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,976	Closed	-$247K	–	61
2014 Q1	$247K	Buy	+12,976	New	+$247K	0.1%	60

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hamilton Lane Advisors's INSM Position: Q2 2014 in Review

Hamilton Lane Advisors sold out of Insmed (INSM) in Q2 2014, closing a stake of 12,976 shares — an estimated $247K sold.

Hamilton Lane Advisors first reported a position in INSM in Q1 2014 and held it in 1 quarter. The position peaked at $247K in Q1 2014. 103 funds tracked by Wall St. Rank hold INSM as of Q2 2014.

Hamilton Lane Advisors reported no remaining Insmed position as of Q2 2014 after selling out during the quarter.
Hamilton Lane Advisors sold 12,976 Insmed shares in Q2 2014, an estimated $247K.
Hamilton Lane Advisors first reported a position in Insmed in Q1 2014 and held it in 1 quarter.
Hamilton Lane Advisors's Insmed position peaked at $247K in Q1 2014.
103 funds tracked by Wall St. Rank held Insmed as of Q2 2014.

Based on Hamilton Lane Advisors's 13F filing for Q2 2014, filed 2 Jul 2014.